Novel immunotherapy combination regimen brings together two complementary therapies to improve outcomes for people living with multiple myeloma as early as second line1 ...

Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...

Ripple (XRP), and Little Pepe (LILPEPE) are emerging as three of the best buys for 2025, and for very different but ...

Ainos at the Edge, ScentAI Scaling AI Intelligence HOUSTON, TX / ACCESS Newswire / January 2, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) today released a statement ...

Mantua-based Marino Allestimenti S.r.l., a specialist in modular event infrastructure, is expanding its support for Christmas market organizers across Europe as cities prepare for the 2025-2026 winter ...

NEW YEAR’S CELEBRATIONS will be occurring all over San Francisco starting Wednesday, but before the clock strikes midnight the city’s public transit ...

New Year’s celebrations will be occurring all over San Francisco starting Wednesday, but before the clock strikes midnight the city’s public transit agency is preparing ...

New Year's celebrations will be occurring all over San Francisco starting Wednesday, but before the clock strikes midnight ...

Dec. 29, GNA – Team Praise Ministry, in partnership with the Celestines Foundation, has supported inmates at the Ho Central Prisons with assorted items to complement efforts aimed ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Since its discovery, Alzheimer's disease has been considered irreversible. Consequently, research has focused on preventing ...